Golden Bird Jewels Pioneers the Rise of Moissanite in the Next-Gen Luxury Market

Golden Bird Jewels Pioneers the Rise of Moissanite in the Next-Gen Luxury Market

(Image showing a newspaper page featuring luxury moissanite jewelry from Golden Bird Jewels)

Started in 2018, Golden Bird Jewels has emerged as a trailblazer in ethical luxury, creating brilliant fine jewelry pieces with Moissanite an ethical gemstone known for its unrivaled sparkle and sustainability. The brand offers stunning engagement rings, earrings, and necklaces that combine innovation with eco-conscious design, redefining what luxury means in the modern age.

Origins and Ethical Vision

Golden Bird Jewels began with a simple but powerful mission: to offer high-end jewelry without the environmental and ethical costs associated with mined diamonds. Founded by a team of visionary artisans in India’s renowned gem-cutting hub, the brand embraced Moissanite as the future of fine jewelry. Moissanite, known for its superior brilliance and ethical sourcing, quickly became the cornerstone of their collections.

From the start, Golden Bird Jewels focused on sustainability, affordability, and beauty making timeless jewelry that reflects both elegance and responsibility. The founders believed that true luxury should not come at the planet’s expense, and that belief is now reflected in every handcrafted piece.

Fast Growth and International Reach

From its humble beginnings, Golden Bird Jewels has rapidly grown into a globally recognized name in sustainable jewelry. The launch of its global e-commerce platform in 2020 enabled the brand to serve thousands of customers across the U.S., Europe, and Asia, offering fast international shipping and personal customer support. With over 200% growth in online Moissanite sales over the past three years, Golden Bird’s reach now extends far beyond India.

After finding major success in the U.S. market where value-conscious and eco-aware consumers embraced its elegant Moissanite collections Golden Bird Jewels officially expanded into the U.K. market in 2025. This move brings its ethically crafted jewelry to a new audience seeking transparency, brilliance, and lasting beauty.

Signature Collections and Bespoke Craftsmanship

Golden Bird Jewels is celebrated for its breathtaking engagement rings, sparkling tennis bracelets, radiant stud earrings, and elegant pendants all created with top-quality Moissanite. Every collection blend traditional artistry with modern design, offering everything from classic solitaires to intricate halo settings.

Customers can also design their dream jewelry with Golden Bird’s bespoke service, where skilled artisans bring visions to life using premium Moissanite stones and recycled precious metals. This custom service is especially popular among couples seeking one-of-a-kind engagement rings that symbolize not only love but conscious living.

Industry Recognition and Moissanite Innovation

Golden Bird Jewels has earned industry-wide appreciation for its dedication to redefining luxury through ethical craftsmanship. The brand’s Moissanite collections are celebrated for their precision cuts, brilliant clarity, and timeless designs that speak to a new generation of conscious consumers.

Driven by innovation, the in-house design team continues to experiment with unique Moissanite shapes, antique-inspired aesthetics, and vibrant gemstone pairings creating signature pieces that combine modern elegance with sustainable values. As more customers seek luxury with purpose, Golden Bird Jewels remains a standout for its ability to blend artistic excellence with ethical responsibility.

Eco-Driven Craftsmanship and Green Commitment

At its core, Golden Bird Jewels is committed to sustainability. Every piece is crafted using ethical Moissanite, recycled gold, and sustainable packaging materials. The company maintains a low carbon footprint by relying on renewable energy in its workshops and supporting local sourcing wherever possible.

Golden Bird also partners with environmental organizations and contributes to reforestation projects, pledging to plant a tree for every Moissanite jewelry sale made. These green efforts reflect a brand culture rooted in transparency and planet-first thinking.

A Brighter Future with Moissanite

As global consumers continue to prioritize ethical sourcing and conscious luxury, Golden Bird Jewels stands at the forefront of this transformation. By championing Moissanite as the new symbol of elegance, the brand offers customers more than jewelry it offers a lifestyle built on integrity, innovation, and timeless beauty.

To explore Golden Bird Jewels’ radiant collections or begin your custom Moissanite journey, visit goldenbirdjewels.com. The future of luxury is sparkling and it’s Moissanite.

Media Contact
Company Name: Golden Bird Jewels
Contact Person: Vijay Sarkheliya
Email: Send Email
Address:30 West 47th Street STE 204
City: New York
State: NY 10036
Country: United States
Website: http://www.goldenbirdjewels.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Golden Bird Jewels Pioneers the Rise of Moissanite in the Next-Gen Luxury Market

Mind Brain Institute Introduces Integrated Mental Health Program for Treatment-Resistant Conditions in New Delhi

Mind Brain Institute launches a 2-week personalized treatment for depression, OCD, PTSD, and anxiety using clinical and holistic methods.

Mind Brain Institute, a mental health clinic based in New Delhi, has launched a structured treatment program that brings together a range of therapeutic approaches for individuals facing treatment-resistant mental health conditions. The program integrates Ketamine-Assisted Psychotherapy (KAP), QEEG-guided Neurofeedback, Heart Rate Variability (HRV) Biofeedback, Brain Mapping, and non-pharmacological neuromodulation tools such as transcranial direct current stimulation (tDCS) and Vagus Nerve Stimulation (VNS).

This two-week protocol is designed for patients diagnosed with depression, obsessive-compulsive disorder (OCD), PTSD, and anxiety disorders who have not responded well to standard treatments. According to the institute, the program is customized based on each individual’s QEEG brain map and HRV stress profile, allowing for a more targeted therapeutic approach.

In addition to neurophysiological techniques, the program incorporates holistic elements such as yoga, breathwork, and sound healing, drawing from both Western clinical frameworks and traditional Eastern wellness practices. The combination of these modalities is intended to support emotional regulation and neural restructuring without an exclusive reliance on medication.

The founder of the institute, Dr. Anuranjan Bist, is a psychiatrist trained in both India and the United States. With over two decades of clinical experience, he has been at the forefront of introducing newer therapeutic modalities like TMS and Ketamine Therapy in India. After years of psychiatric practice in the US, Dr. Bist returned to India with the aim of making newer clinical protocols more accessible within the country.

“Our objective is to offer a medical setting where neuroscience-based tools can work alongside complementary therapies to improve outcomes for those who have exhausted traditional options,” said Dr. Bist. “This approach is not focused only on symptom relief but also on long-term functional recovery.”

The institute reports that each therapy included in the program has been selected for its role in modulating the nervous system. For example, Neurofeedback aims to regulate brainwave patterns through real-time monitoring, while HRV training is used to strengthen autonomic balance. Transcranial stimulation and VNS apply mild electrical impulses to influence specific brain circuits involved in emotional processing.

Supportive therapies such as Tibetan sound healing and mindfulness-based yoga are used to reinforce physiological relaxation and help maintain treatment effects. These elements are led by Sandra Kappler, an educator and certified therapist with training in trauma and special education, who co-leads the center’s integrative wellness initiatives.

Mind Brain Institute operates centers in both India and the United States and has treated more than 3,000 patients to date. With this recent launch, the team hopes to expand access to structured, precision-focused care that addresses both biological and psychological dimensions of mental health.

To learn more, visit: https://mindbraintms.com or email info@mindbraintms.com

For the latest updates, follow Mind Brain Institute on Social Media.

Instagram: @mindbraininstitute

Facebook: @MindBrainTms

YouTube: @MindBrainTms

About Company:

Mind Brain Institute is a mental health clinic based in New Delhi offering evidence-based psychiatric and integrative therapies. The center focuses on non-pharmacological approaches for individuals who have not found relief through standard treatment methods.

Media Contact
Company Name: Mind Brain Institute
Contact Person: Dr. Anuranjan Bist
Email: Send Email
City: New Delhi
State: Delhi
Country: India
Website: mindbraintms.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Mind Brain Institute Introduces Integrated Mental Health Program for Treatment-Resistant Conditions in New Delhi

The Fashion Revolution That’s Rewriting India’s Style Story – One Bold Design at a Time

Kolkata’s Best-Kept Secret Just Went Nationwide: Meet Store No.6, Where Traditional Meets Rebellious.

Kolkata’s Best-Kept Secret Just Went Nationwide: Meet Store No.6, Where Traditional Meets Rebellious

What happens when a visionary designer decides to throw the fashion rulebook out the window? Store No.6 happened.

Picture this: It’s 2 AM, and you just remembered your best friend’s sangeet is this weekend. Panic mode? Not anymore. While other boutiques leave you hanging for weeks, Store No.6 delivers luxury fashion to your doorstep in just 48 hours. And right now, they’re celebrating their nationwide expansion with a jaw-dropping ₹1000 discount (code: S1000) because apparently, looking fabulous shouldn’t break the bank.

The Visionary Behind the Revolution

Srotoswini Majumdar didn’t just start a fashion brand—she orchestrated a cultural shift. From her creative sanctuary in Kolkata, this powerhouse designer is challenging India’s fashion landscape with collections that refuse to be categorized. Her philosophy is radical in its simplicity: why should Indian women choose between honoring their heritage and embracing contemporary style?

Operating under Srotoswini Sixth No Store Opc Pvt Ltd, Majumdar has assembled a predominantly female team of designers and artisans who share her vision of inclusive, empowering fashion. Each collection reflects her artistic approach to fusion wear, where traditional Indian motifs dance with modern sensibilities, creating pieces that speak to the multifaceted identity of today’s Indian woman.

Her journey began with a simple observation: the Indian fashion market was saturated with either completely traditional wear or Western clothing with superficial Indian elements. There was a void for authentic fusion pieces that celebrated both aspects of a modern Indian woman’s identity without compromising on either.

Deconstructing the Store No.6 Difference

The Architecture of Statement Blouses

Store No.6’s blouses are engineering marvels disguised as clothing. These aren’t mere tops—they’re conversation starters, confidence boosters, and works of art. Picture dramatic balloon sleeves that create sculptural silhouettes, asymmetrical necklines that frame the face perfectly, and intricate back details that transform a simple saree into red-carpet worthy attire.

The construction techniques employed are notably sophisticated. Each blouse undergoes meticulous tailoring to accommodate different body types while maintaining the integrity of the design. The fabrics range from luxurious silk blends to structured cotton weaves, each chosen specifically for its drape and durability. What sets these pieces apart is their versatility—a single blouse can be styled with traditional sarees, modern skirts, or even contemporary jeans, making it a worthy investment for any wardrobe.

Sarees That Challenge Convention

The Store No.6 saree collection represents a masterclass in respectful innovation. Each six-yard piece maintains the soul of traditional Indian draping while incorporating elements that speak to contemporary sensibilities. The color palettes are deliberately unexpected—think deep burgundy paired with metallic gold, or soft pastels accented with bold geometric patterns.

The blouse designs that accompany these sarees are particularly noteworthy. Instead of standard fitted tops, customers receive pieces with cape sleeves, off-shoulder cuts, or dramatic back details that transform the entire ensemble. The draping techniques suggested by the brand offer modern interpretations that are both comfortable and photogenic—essential qualities for today’s socially-conscious fashion consumer.

Indo-Western: The Perfect Balance

Perhaps the most challenging category in contemporary Indian fashion, Indo-western wear often falls into the trap of being neither here nor there. Store No.6 has mastered this delicate balance by focusing on structural integrity rather than superficial fusion.

Their palazzo sets feature traditional Indian silhouettes in fabrics and cuts that wouldn’t look out of place in a European fashion house. The kurta-style tops are tailored with Western precision, incorporating princess seams and structured shoulders that create flattering silhouettes for all body types. The result is clothing that feels authentically Indian while meeting the practical needs of modern life.

The brand’s approach to Indo-western wear extends beyond mere aesthetics. Each piece is designed with the understanding that contemporary Indian women need clothing that transitions seamlessly from office environments to social gatherings, from air-conditioned spaces to humid outdoor events.

Curated Combos and Dress Collections

Store No.6’s ready-to-wear collections demonstrate the brand’s understanding of modern lifestyle demands. The coordinated sets are designed with mix-and-match capabilities, allowing customers to create multiple looks from a single purchase. The dresses, while maintaining Indian design sensibilities, are cut and constructed using international fashion techniques.

The festive wear collection deserves special mention for its thoughtful approach to celebration dressing. These pieces are designed to photograph beautifully under various lighting conditions while remaining comfortable enough for extended wear. The fabrics are chosen for their ability to maintain shape and appearance throughout long events, and the cuts accommodate the movement required for dancing and socializing.

The Operational Excellence That Drives Success

Revolutionary 48-Hour Dispatch System

Store No.6’s express dispatch capability represents a significant operational achievement in the Indian fashion e-commerce space. This system requires sophisticated inventory management, streamlined production processes, and strategic partnerships with logistics providers. The 48-hour promise applies to express orders and reflects the brand’s commitment to meeting the urgent fashion needs of contemporary consumers.

The operational infrastructure supporting this service includes real-time inventory tracking, automated order processing systems, and strategic warehouse locations that enable rapid fulfillment. This capability has particular relevance in the Indian market, where last-minute fashion needs are common due to the frequency of social and religious celebrations.

Quality Control and Craftsmanship Standards

Each garment undergoes rigorous quality control processes that examine fabric quality, construction techniques, and finishing details. The brand’s commitment to premium-grade materials is evident in the selection of fabrics, which are sourced from established textile manufacturers known for their consistency and durability.

The artisanal detailing that characterizes Store No.6 pieces requires skilled craftsmanship that the brand has cultivated through partnerships with experienced artisans. This approach not only ensures product quality but also supports traditional Indian textile crafts, creating a sustainable ecosystem that benefits both the brand and the broader artisan community.

Market Positioning and Consumer Response

Target Demographics and Psychographics

Store No.6 has identified and successfully captured a specific segment of the Indian fashion market: educated, financially independent women who value both tradition and modernity. This demographic includes working professionals, entrepreneurs, and women who frequently attend social events requiring distinctive attire.

The brand’s success lies in understanding that these consumers don’t want to choose between cultural authenticity and contemporary style. They seek clothing that reflects their complex identity as modern Indian women who are globally aware yet culturally rooted.

Customer Testimonials and Market Validation

The brand’s customer feedback reveals consistent themes: appreciation for unique designs, satisfaction with quality, and gratitude for the express delivery service. Customers frequently mention the confidence boost they experience when wearing Store No.6 pieces, indicating that the brand has successfully achieved its goal of creating empowering fashion.

The testimonials also highlight the brand’s success in creating truly versatile pieces. Customers report styling single items in multiple ways, maximizing the value of their purchases while expanding their wardrobe options.

Competitive Advantage in the Indian Fashion Market

Store No.6 has carved out a unique position in the crowded Indian fashion market by focusing on authentic fusion rather than superficial trend-following. While many brands either stick strictly to traditional designs or completely abandon Indian aesthetics, Store No.6 has found the sweet spot that honors both cultural heritage and contemporary needs.

The brand’s woman-owned and operated status also provides a competitive advantage in an increasingly conscious consumer market. Customers appreciate supporting businesses that align with their values, particularly those that empower women and support traditional craftsmanship.

Strategic Vision and Future Implications

Scaling Sustainable Fashion Practices

Store No.6’s approach to fashion production emphasizes quality over quantity, encouraging consumers to invest in versatile pieces rather than disposable trends. This philosophy aligns with growing consumer awareness about sustainable fashion practices and positions the brand favorably for long-term success.

The brand’s support for female artisans and entrepreneurs creates a positive economic impact that extends beyond immediate sales. By maintaining these partnerships as the business scales, Store No.6 contributes to the broader development of India’s fashion ecosystem.

Cultural Impact and Industry Influence

Store No.6’s success demonstrates the market viability of thoughtful fusion fashion, potentially influencing other brands to adopt similar approaches. The brand’s emphasis on celebrating different body types and personal styles challenges industry norms and contributes to more inclusive fashion representation.

The company’s rapid growth and positive consumer response suggest that there is significant untapped demand for authentic Indo-western fashion that respects cultural heritage while embracing contemporary aesthetics.

Conclusion

The fashion landscape is evolving, and Store No.6 represents the direction that thoughtful, culturally-aware fashion is heading. For consumers who refuse to compromise between tradition and modernity, between style and substance, between cultural authenticity and contemporary relevance, Store No.6 offers a compelling solution.

The current ₹1000 discount opportunity (code: S1000) represents more than a promotional offer—it’s an invitation to join a movement that celebrates the complexity and beauty of modern Indian womanhood through fashion that empowers rather than constrains.

Visit Storeno6.com today and discover what happens when heritage meets innovation, when tradition meets rebellion, and when fashion becomes a celebration of identity rather than its limitation.

Store No.6 – Where Every Woman Finds Her Power Outfit Srotoswini Sixth No. Store Opc Pvt Ltd | Kolkata, India

Media Contact
Company Name: STORE NO.6
Email: Send Email
Phone: 062912 26312
Address:12/2 Gobindapur Road, Lake Gardens
City: Kolkata
State: West Bengal
Country: India
Website: https://www.storeno6.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Fashion Revolution That’s Rewriting India’s Style Story – One Bold Design at a Time

Viaticum Barbers Unveils Oslo’s Ultimate Grooming Destination for Modern Men

Oslo, Norway – July 14, 2025 – In the vibrant heart of Bislett, where historic charm meets contemporary flair, Viaticum Barbers has emerged as the definitive barbershop for modern gentlemen. With a philosophy rooted in craftsmanship, individuality, and exceptional service, Viaticum is rewriting the grooming experience in Oslo—one haircut, beard trim, and hot towel shave at a time.

From the moment clients step inside the welcoming, tastefully designed studio on Dalsbergstien 16C, they sense they are entering more than just a barbershop. Viaticum Barbers is a gallery for self-expression, meticulous detail, and character—a place where tradition meets innovation, where every visit becomes a personal journey of care and confidence.

More information can be found at https://barbers.viaticumgallery.com.

A Heritage of Craftsmanship and Style

In an era where speed and convenience often eclipse quality, Viaticum Barbers has chosen a different path. Their approach is anchored in time-honored techniques combined with modern sensibilities. Whether you are seeking a classic gentleman’s cut, a contemporary fade, or a rejuvenating facial treatment, the skilled team ensures that no detail is overlooked.

“We believe that grooming is more than just a routine—it’s a celebration of individual style,” says the Viaticum team. “When you sit in our chair, you can trust that our barbers will take the time to understand who you are and what makes you feel your best.”

This commitment to excellence has earned Viaticum Barbers a 5-star reputation, backed by over 250 glowing reviews from satisfied clients on Google. From executives to artists and students, men across Oslo are discovering that a visit to Viaticum is a refreshing departure from the ordinary.

Comprehensive Services Designed for the Modern Gentleman

Viaticum Barbers offers a thoughtfully curated menu of services to meet the needs of every client. The service range includes:

  • Haircuts and Head Shaving: From timeless classics to trend-forward styles.

  • Beard Trims and Hot Towel Shaves: Rediscover the luxury and precision of a traditional shave.

  • Hair Coloring and Bleaching: For those who want to enhance or transform their look.

  • Facial Treatments: Revitalize and refresh with premium skin care.

  • Styling: Professional finishing to keep you looking sharp all week.

  • Exclusive Products: Pomades, beard oils, and signature fragrances designed to complement your style.

Every treatment at Viaticum is delivered with precision, comfort, and an unwavering dedication to quality, ensuring each client leaves not only looking their best but feeling renewed.

The Viaticum Experience: Where Self-Care Meets Artistry

What sets Viaticum Barbers apart is the unique blend of artistic inspiration and warm professionalism. Inspired by the notion that grooming is both a craft and an art form, the team treats each appointment as an opportunity to create something special.

Step into the contemporary studio, and you’ll notice the subtle nods to Scandinavian design—clean lines, natural materials, and a calming color palette. This soothing environment is carefully curated to make clients feel instantly at ease.

The signature hot towel shave, often described as a “luxurious ritual,” has become a must-try experience for first-time visitors and regulars alike. According to the team, “There are few moments more satisfying than the warm embrace of a hot towel and the smooth finish of a precise shave.”

Bislett: A Neighborhood with Character

For Viaticum Barbers, location is no accident. Bislett is a dynamic neighborhood with an eclectic blend of cafés, boutiques, and cultural spaces. Its rich history and progressive energy reflect Viaticum’s own mission to honor the best of tradition while embracing the future.

“Bislett is a place where old meets new, and that’s exactly the spirit we wanted to embody in our barbershop,” the founders explain. “We want clients to feel connected to the neighborhood while enjoying a service that feels fresh and elevated.”

This strategic choice has also made Viaticum a popular drop-in barbershop for busy professionals and travelers who need quality grooming on short notice. With flexible hours from Monday to Saturday and walk-in appointments available, Viaticum makes it easy to look your best on your schedule.

The Digital Experience: Style at Your Fingertips

Viaticum Barbers understands that modern clients expect seamless online experiences alongside exceptional in-person service. The shop’s intuitive website makes scheduling effortless. Visitors can explore the service menu, view the gallery of styles, read the blog, and reserve appointments in just a few clicks.

Highlights of the website include:

  • Gallery of Work: See real examples of Viaticum’s artistry, from classic cuts to contemporary styles.

  • Expert Blog: Discover grooming tips, beard care guides, and the latest trends in men’s hair.

  • FAQ Section: Find answers to common questions about services, booking, and products.

  • Secure Online Booking: Choose your preferred time and service with instant confirmation.

For those unsure of which service is right for them, Viaticum encourages new clients to book a consultation. The team is always ready to provide guidance and recommendations tailored to your hair type, lifestyle, and personal aesthetic.

A Commitment to Individuality

At its core, Viaticum Barbers is driven by a single purpose: to help every client express their identity with confidence. The barbers understand that hair is more than just hair—it’s a reflection of how you see yourself and how you move through the world.

“It’s about creating an experience where every man feels seen and valued,” the team says. “When you look in the mirror and feel that boost of confidence, that’s when we know we’ve done our job.”

From teenagers discovering their style to seasoned professionals perfecting their look, Viaticum welcomes men of all ages and backgrounds. This inclusive approach has solidified the shop’s standing as Oslo’s most trusted barbershop for discerning clients.

Visit Viaticum Barbers

Whether you’re preparing for an important meeting, a special occasion, or simply want to look and feel your best, Viaticum Barbers is ready to welcome you. With a combination of skilled craftsmanship, personalized service, and a passion for style, Viaticum is setting a new standard for men’s grooming in Oslo.

Location: Viaticum Barbers, Dalsbergstien 16C 0170 Oslo, Norway

Opening Hours: Monday – Friday: 12:00 PM – 8:00 PM, Saturday: 12:00 PM – 8:00 PM, Sunday: Closed

Phone : +47 413 10 723

Book Your Appointment Today

Don’t wait to experience Oslo’s premier grooming destination. Visit Viaticum Barbers online to schedule your appointment, explore their services, or simply discover why so many men have made Viaticum their barbershop of choice.

Because when it comes to your style, you deserve nothing less than the best.

Media Contact
Company Name: Viaticum Barbers
Email: Send Email
Phone: 41310723
Address:Dalsbergstien 16C
City: 0170 Oslo
Country: Norway
Website: https://barbers.viaticumgallery.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Viaticum Barbers Unveils Oslo’s Ultimate Grooming Destination for Modern Men

Chicago Gutter Pros Launches New Website to Improve Access to Gutter Cleaning, Repair, and Installation Services in Chicago

““We created this platform to make it easier for homeowners to find reliable gutter services without the hassle,” said Steve Miller, founder of Chicago Gutter Pros. “With Chicago’s unpredictable weather, timely gutter maintenance isn’t optional—it’s essential for protecting your home.””
Chicago Gutter Pros has launched a new website to connect Chicago-area homeowners with trusted gutter cleaning, repair, and installation services. The platform offers easy access to licensed contractors for gutter maintenance, seamless installation, and downspout repair. Visit chicagogutterpros.com or call (312) 281-7473 for more information.

Chicago, IL – July 14, 2025 – A new digital platform has launched to bridge the gap between homeowners and professional gutter service providers in the greater Chicago area. Chicago Gutter Pros, founded by local entrepreneur Steve Miller, is proud to announce the official launch of its new website: https://chicagogutterpros.com. This platform is designed to streamline access to trusted gutter repair, installation, and cleaning services in Chicago, Illinois and surrounding areas.

The website aims to meet the growing demand for dependable and top quality gutter services across residential and commercial properties. Offering a centralized resource for gutter installation, gutter cleaning, seamless gutter installation, gutter repair, and downspout repair, the platform simplifies the search process for homeowners needing urgent or scheduled maintenance.

“We saw a clear need for a dedicated, local solution,” said Steve Miller, founder of Chicago Gutter Pros. “With unpredictable weather and heavy rainfall common in Chicago, well-maintained gutters are essential for every property owner. Our goal is to help homeowners access quality care and avoid long-term water damage or mold growth through proper gutter system upkeep.”

Meeting Critical Gutter Needs in the Chicago Area

The Chicago IL region frequently experiences seasonal storms, snow, and ice dams, all of which can wreak havoc on gutters, soffit, fascia, and roof structures. The Chicago Gutter Pros website provides access to a curated list of local gutter experts ready to address everything from clogged gutters and leaks to custom manufactured seamless gutters and full gutter repair installation packages.

With services tailored to both residential homes and commercial gutters, the platform supports routine cleaning, urgent repair, and complete replacement of aging systems. Homeowners can request a free quote directly through the site or call (312) 281-7473 to speak with a representative.

The business is headquartered at 2555 Lincoln Hwy, Olympia Fields, IL 60461, making it well-positioned to serve neighborhoods throughout Chicago Illinois.

Why Maintenance Matters

Many homeowners underestimate the impact of neglected gutters. Overflowing systems can cause serious water damage to siding, roofing, and even foundations. With regular gutter cleaning services, including top quality gutter cleaning, Chicago Gutter Pros helps prevent debris buildup that leads to costly repairs.

The new website breaks down the entire cleaning process and includes educational content for those looking to understand their maintenance needs, from vinyl siding protection to roof drainage.

“It’s not just about appearance or curb appeal,” Miller added. “It’s about protecting your home’s protection investment—your house, your garage, your property. Even a broken gutter or small clog can result in major issues if not resolved quickly.”

Expanding Local Access to Quality Gutter Work

Chicago Gutter Pros collaborates with a network of licensed professionals to handle everything from seamless gutters to gutter guards, siding, and fascia replacement. The site offers detailed service descriptions for:

  • Gutter cleaning (routine and seasonal)

  • Gutter repair and downspout repair

  • Seamless gutter installation

  • Aluminum, copper, and custom manufactured solutions

  • Full installation and replacement of gutters, roof connections, and soffit/fascia systems

With options available for both homes and commercial properties, the platform positions itself as a go-to resource for services in Chicago.

Community and Customer Focused

Chicago Gutter Pros stands out for its emphasis on customer care and transparency. The website allows users to explore services, learn how gutters work, understand when a gutter system needs repair, and even browse tips to improve curb appeal. The company is committed to offering clear guidance, top quality work, and responsive support from the initial call to the final result.

Whether a homeowner is dealing with clogged gutters, ice dams, sagging downspouts, or aging aluminum systems, the platform is designed to guide users to the help they need. The team also focuses on keeping the job site safe, clean, and minimally disruptive.

By leveraging local talent and focusing on super helpful, informative service, Chicago Gutter Pros has already begun to build a reputation as a reliable source of gutter services across Chicago Illinois.

About Chicago Gutter Pros

Founded in 2000 by Steve Miller, Chicago Gutter Pros is a local resource designed to connect homeowners and businesses with experienced professionals offering gutter installation, gutter repair, and cleaning across Chicago IL. With a strong focus on quality, maintenance, and long-term roof and siding protection, the company emphasizes durability, efficiency, and top quality gutter services.

Media Contact
Company Name: Chicago Gutter Pros
Contact Person: Steve Miller
Email: Send Email
Phone: (312) 281-7473
Address:2555 Lincoln Hwy Olympia Fields
City: Chicago
State: Illinois 60461
Country: United States
Website: https://chicagogutterpros.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chicago Gutter Pros Launches New Website to Improve Access to Gutter Cleaning, Repair, and Installation Services in Chicago

Spinal Cord Injury Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved By DelveInsight | StemCyte, NervGen Pharma, VA Office of Research and Development, Kessler

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spinal Cord Injury pipeline constitutes 25+ key companies continuously working towards developing 30+ Spinal Cord Injury treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

 

Spinal Cord Injury Pipeline Insight, 2025 report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinal Cord Injury Market.

 

The Spinal Cord Injury Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

Some of the key takeaways from the Spinal Cord Injury Pipeline Report:

  • Companies across the globe are diligently working toward developing novel Spinal Cord Injury treatment therapies with a considerable amount of success over the years.

  • Spinal Cord Injury companies working in the treatment market are Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others, are developing therapies for the Spinal Cord Injury treatment

  • Emerging Spinal Cord Injury therapies in the different phases of clinical trials are- Allogeneic stem cell therapy, OLT1177, ALMB0166, AXER-204, FAB117-HC, AST-OPC1, Elezanumab, MT 3921, PMZ-1620, ES 135, KP-100IT, NVG-291, Romosozumab, Umbilical Cord Blood Mononuclear Cell, and others are expected to have a significant impact on the Spinal Cord Injury market in the coming years.

  • In June 2025, Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotech company focused on developing innovative allogeneic (“off-the-shelf”) cell therapies for severe neurological and ophthalmic disorders, announced the addition of new presenters for the 3rd Annual Spinal Cord Injury Investor Symposium (3rd SCIIS). This year’s event will be entirely virtual, featuring interactive and on-demand sessions beginning on June 27, 2025.

  • In March 2025, Cellino and Matricelf (TASE: MTLF) announced a partnership aimed at advancing the global biomanufacturing of personalized spinal cord injury therapies. This collaboration integrates Cellino’s Nebula™ technology with Matricelf’s innovative regenerative medicine approach. By combining Cellino’s automated production of induced pluripotent stem cells (iPSCs) with Matricelf’s double autologous 3D differentiation process, the partnership seeks to enable scalable and patient-specific regenerative treatments. Cellino’s Nebula™, a proprietary closed-cassette biomanufacturing platform, is specifically designed to generate high-quality iPSCs with exceptional consistency and sterility at a large scale.

  • In March 2025, NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) announced the successful completion of a key preclinical study supporting its upcoming Investigational New Drug (IND) application. This study marks a significant step toward the company’s first-in-human trials. The results demonstrated that ExoPTEN treatment, across various dosing regimens, promoted motor function recovery and notably enhanced blood flow at the spinal cord injury site—both critical factors for tissue repair and functional improvement.

  • In February 2025, Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotech company developing allogeneic cell therapies for severe neurological disorders, announced the launch of its DOSED (Delivery of Oligodendrocyte Progenitor Cells for Spinal Cord Injury: Evaluation of a Novel Device) clinical study. This study aims to assess the safety and performance of the Manual Inject Parenchymal Spinal Delivery System (MI PSD System), a new device designed to precisely deliver OPC1, an investigational allogeneic stem cell-based therapy, directly to the spinal cord injury site. OPC1 consists of oligodendrocyte progenitor cells and other related glial cells intended to promote spinal cord repair.

  • In February 2025, A pilot clinical trial suggests that spinal cord stimulation (SCS) may help reactivate dormant motor neurons and enhance leg muscle strength in individuals with spinal muscular atrophy (SMA). Researchers from the University of Pittsburgh School of Medicine conducted the study (NCT05430113), utilizing Medtronic’s Vectris SureScan device in three SMA patients. After three months of treatment, all participants showed an improvement of at least 20 meters in the six-minute walk test (6MWT), an indicator used to assess muscle endurance and fatigue.

 

Spinal Cord Injury Overview

Spinal Cord Injury (SCI) is damage to the spinal cord that disrupts communication between the brain and the rest of the body. This can result from trauma (e.g., accidents, falls) or diseases (e.g., tumors, infections). SCI can lead to partial or complete loss of motor function, sensation, and autonomic control below the injury site. It may cause paralysis (paraplegia or quadriplegia) and complications like respiratory issues, bladder dysfunction, and chronic pain. Treatment focuses on stabilizing the spine, rehabilitation, and therapies to restore function and improve quality of life, with ongoing research into advanced regenerative approaches.

 

Get a Free Sample PDF Report to know more about Spinal Cord Injury Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/spinal-cord-injury-pipeline-insight

 

Emerging Spinal Cord Injury Drugs Under Different Phases of Clinical Development Include:

  • Allogeneic stem cell therapy: Athersys

  • OLT1177: Olatec Therapeutics

  • ALMB0166: AlaMab therapeutics

  • AXER-204: ReNetX Bio

  • FAB117-HC: Histocell

  • AST-OPC1: Lineage Cell Therapeutics

  • Elezanumab: AbbVie

  • MT 3921: Mitsubishi Tanabe Pharma

  • PMZ-1620: Pharmazz

  • ES 135: Eusol Biotech

  • KP-100IT: Kringle Pharma

  • NVG-291: NervGen Pharma

  • Romosozumab: VA Office of Research and Development/Kessler Institute for Rehabilitation

  • Umbilical Cord Blood Mononuclear Cell: StemCyte, Inc

 

Spinal Cord Injury Route of Administration

Spinal Cord Injury pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

  • Oral

  • Parenteral

  • Intravenous

  • Subcutaneous

  • Topical

 

Spinal Cord Injury Molecule Type

Spinal Cord Injury Products have been categorized under various Molecule types, such as

  • Monoclonal Antibody

  • Peptides

  • Polymer

  • Small molecule

  • Gene therapy

 

Spinal Cord Injury Pipeline Therapeutics Assessment

  • Spinal Cord Injury Assessment by Product Type

  • Spinal Cord Injury By Stage and Product Type

  • Spinal Cord Injury Assessment by Route of Administration

  • Spinal Cord Injury By Stage and Route of Administration

  • Spinal Cord Injury Assessment by Molecule Type

  • Spinal Cord Injury by Stage and Molecule Type

 

DelveInsight’s Spinal Cord Injury Report covers around 30+ products under different phases of clinical development like

  • Late-stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I)

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

  • Route of Administration

 

Further Spinal Cord Injury product details are provided in the report. Download the Spinal Cord Injury pipeline report to learn more about the emerging Spinal Cord Injury therapies

 

Some of the key companies in the Spinal Cord Injury Therapeutics Market include:

Key companies developing therapies for Spinal Cord Injury are – NervGen Pharma, VA Office of Research and Development, Kessler Institute for Rehabilitation, StemCyte, Inc., Mitsubishi Tanabe Pharma America Inc., AbbVie, and others.

 

Spinal Cord Injury Pipeline Analysis:

The Spinal Cord Injury pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Spinal Cord Injury with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Spinal Cord Injury Treatment.

  • Spinal Cord Injury key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Spinal Cord Injury Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Spinal Cord Injury market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Spinal Cord Injury drugs and therapies

 

Spinal Cord Injury Pipeline Market Drivers

  • Increase in prevalence of spinal cord injury, increasing awareness about the spinal cord injury are some of the important factors that are fueling the Spinal Cord Injury Market.

 

Spinal Cord Injury Pipeline Market Barriers

  • However, absence of essential emergency and acute care, lack of importance of a systematic approach towards the management of Spinal cord Injury and other factors are creating obstacles in the Spinal Cord Injury Market growth.

 

Scope of Spinal Cord Injury Pipeline Drug Insight

  • Coverage: Global

  • Key Spinal Cord Injury Companies: Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others

  • Key Spinal Cord Injury Therapies: Allogeneic stem cell therapy, OLT1177, ALMB0166, AXER-204, FAB117-HC, AST-OPC1, Elezanumab, MT 3921, PMZ-1620, ES 135, KP-100IT, NVG-291, Romosozumab, Umbilical Cord Blood Mononuclear Cell, and others

  • Spinal Cord Injury Therapeutic Assessment: Spinal Cord Injury current marketed and Spinal Cord Injury emerging therapies

  • Spinal Cord Injury Market Dynamics: Spinal Cord Injury market drivers and Spinal Cord Injury market barriers

 

Request for Sample PDF Report for Spinal Cord Injury Pipeline Assessment and clinical trials

 

Table of Contents

1. Spinal Cord Injury Report Introduction

2. Spinal Cord Injury Executive Summary

3. Spinal Cord Injury Overview

4. Spinal Cord Injury- Analytical Perspective In-depth Commercial Assessment

5. Spinal Cord Injury Pipeline Therapeutics

6. Spinal Cord Injury Late Stage Products (Phase II/III)

7. Spinal Cord Injury Mid Stage Products (Phase II)

8. Spinal Cord Injury Early Stage Products (Phase I)

9. Spinal Cord Injury Preclinical Stage Products

10. Spinal Cord Injury Therapeutics Assessment

11. Spinal Cord Injury Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Spinal Cord Injury Key Companies

14. Spinal Cord Injury Key Products

15. Spinal Cord Injury Unmet Needs

16 . Spinal Cord Injury Market Drivers and Barriers

17. Spinal Cord Injury Future Perspectives and Conclusion

18. Spinal Cord Injury Analyst Views

19. Appendix

20. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Spinal Cord Injury Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved By DelveInsight | StemCyte, NervGen Pharma, VA Office of Research and Development, Kessler

Apéritif Fine Dining Restaurant Named One of Indonesia’s Top 30 Restaurants at Prestige Gourmet Awards 2025

“Apéritif – Fine Dining Restaurant in Ubud, Bali”

Ubud, Bali – July 14, 2025 – Apéritif Restaurant, the acclaimed fine-dining restaurant nestled in the cultural heart of Ubud, is proud to announce its inclusion in the Top 30 Best Restaurants in Indonesia by the Prestige Gourmet Awards 2025. This esteemed honour, bestowed by Prestige Indonesia, celebrates culinary excellence, innovation, and an unwavering commitment to hospitality.

Now in its third year, the Prestige Gourmet Awards is one of Indonesia’s most respected culinary accolades, spotlighting exceptional restaurants, chefs, and gastronomic experiences across the nation. Apéritif’s inclusion in the 2025 list reflects its continued pursuit of excellence and its influence on shaping the future of Indonesia’s fine dining landscape.

A Landmark Recognition for Bali’s Fine Dining Scene

Located within the lush estate of the Viceroy Bali, Apéritif Restaurant is renowned for its immersive degustation experiences that combine global techniques with Indonesian ingredients. Under the visionary direction of Executive Chef Nic Vanderbeeken, Apéritif crafts tasting menus that tell a story—where every course celebrates both culinary artistry and cultural heritage.

“Being named among Indonesia’s top 30 restaurants is a humbling and proud moment for our entire team,” said Chef Nic Vanderbeeken. “It reflects years of passion, dedication, and the drive to continuously evolve while honouring Bali’s natural bounty and rich traditions.”

Innovative Dining in a Timeless Setting

Set in a grand 1920s-inspired dining room, Apéritif offers guests a multi-sensory journey marked by sophisticated flavours, elegant presentation, and warm Balinese hospitality. Signature elements include the chef’s tasting menu, vegetarian alternatives and a curated wine cellar.

A Destination for Culinary Pilgrims

Apéritif’s recognition by the Prestige Gourmet Awards 2025 places it among an elite group of establishments pushing the boundaries of Indonesia’s culinary potential. The award further cements Ubud as a culinary destination and reflects the global appeal of Bali’s fine dining scene.

“This recognition affirms our commitment to delivering a dining experience that is thoughtful, world-class, and deeply rooted in our local context,” said Patrick Farrell, General Manager of Viceroy Bali. “We extend our heartfelt gratitude to Prestige Indonesia and to our guests who continue to inspire us.”

Reservations and Inquiries

Apéritif is open daily for lunch and dinner, offering fine dining tasting menus to reflect the best of local produce and culinary creativity. You can visit the Ubud fine dining restaurant here.

Apéritif Restaurant

Br. Nagi, Jl. Lanyahan, Petulu Kecamatan Ubud, Kabupaten Gianyar, Bali 80571, Indonesia

Phone: +62 361 908 2 777

Email: res@aperitif.com

Website: https://www.aperitif.com/

For media visit online-media-room

Contact: Ni N Suryantini (Surya)

Media Contact
Company Name: Apéritif Restaurant
Contact Person: Patrick Farrell
Email: Send Email
Address:Br. Nagi, Jl. Lanyahan, Petulu Kecamatan Ubud, Kabupaten Gianyar
City: Ubud
State: Bali, 80571
Country: Indonesia
Website: https://www.aperitif.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Apéritif Fine Dining Restaurant Named One of Indonesia’s Top 30 Restaurants at Prestige Gourmet Awards 2025

BeamMed Inc. Unveils Next-Generation Diagnostic Solutions: The Mini Omni™ Bone Density Scanner and AI-Powered Fundus Camera Lead the Way in Preventive Healthcare

“Portable Diagnostic Devices”
BeamMed Inc. launches two groundbreaking preventative diagnostic devices—the Mini Omni™ Bone Density Scanner and AI-Powered Fundus Camera—designed to improve early detection of conditions like osteoporosis and diabetic retinopathy. These portable, innovative tools bring accessible, accurate screening to clinics, hospitals, and mobile care providers nationwide.

BeamMed Inc., a recognized global innovator in medical diagnostic technology, proudly announces a major step forward in preventive healthcare with two groundbreaking product offerings: the Mini Omni™ Portable Bone Density Scanner and the newly released AI-Powered Fundus Camera. Designed to empower clinicians with advanced tools for early detection of serious health conditions, these devices showcase BeamMed’s ongoing commitment to accessibility, innovation, and excellence in diagnostic care.

Bridging the Gap Between Early Detection and Accessibility

In today’s evolving healthcare landscape, the need for portable, accurate, and cost-effective diagnostic solutions is more important than ever. BeamMed’s new line of diagnostic devices is designed to bridge this gap—bringing high-level diagnostic capabilities to hospitals, clinics, and mobile healthcare providers.

“Preventive healthcare starts with early detection. By integrating cutting-edge technology into compact, affordable devices, we’re allowing healthcare professionals to diagnose serious conditions like osteoporosis and diabetic retinopathy at an earlier stage and in more locations,” said Gilad Zamir, of BeamMed Inc.

Mini Omni™: Compact Innovation in Bone Health Screening

The Mini Omni™ stands at the forefront of portable bone density assessment. Unlike traditional DEXA scans that require large, expensive equipment and emit radiation, the Mini Omni™ uses ultrasound technology to deliver precise bone density measurements at peripheral sites such as the radius, tibia, and phalanges. This makes it an ideal choice for osteoporosis screening, fracture risk assessment, and ongoing monitoring.

Key features of the Mini Omni™ include:

  • Radiation-free technology using quantitative ultrasound
  • Compact and lightweight design for easy transportation
  • Intuitive touchscreen interface with multilingual software
  • Bluetooth connectivity for seamless data transfer
  • FDA-cleared and CE-marked for clinical use worldwide

Its portability and ease of use make it ideal for use in hospitals, long-term care facilities, outpatient clinics, wellness fairs, and mobile health units. In areas with limited access to diagnostic imaging services, the Mini Omni™ offers a practical and affordable alternative, helping providers intervene before fractures or complications occur.

AI-Powered Fundus Camera: Intelligent Eye Screening for Everyone

BeamMed’s newest product offering, the AI-Powered Fundus Camera, introduces a paradigm shift in ocular diagnostics. Designed for non-mydriatic retinal imaging, this device provides high-resolution images of the retina without the need for pupil dilation—making the exam more comfortable for patients and faster for providers.

But what truly sets this device apart is its built-in artificial intelligence engine. The integrated AI analyzes the images in real time to identify early signs of:

  • Diabetic Retinopathy
  • Glaucoma
  • Age-Related Macular Degeneration (AMD)

These conditions are leading causes of vision loss worldwide, yet they often progress silently and undetected. With this fundus camera, general practitioners, endocrinologists, and optometrists can conduct routine retinal screenings in-office and make timely referrals, improving patient outcomes dramatically.

Highlights of the AI-Powered Fundus Camera:

  • Real-time AI diagnostic support
  • Wi-Fi enabled for instant data sharing
  • High-definition retinal images with auto-focus
  • Portable and user-friendly design
  • No dilation required, improving patient comfort and exam efficiency

Ideal for primary care settings, diabetic care management programs, and rural outreach, the fundus camera is set to expand access to sight-saving screenings and elevate early intervention in eye health.

Advancing Preventive Care Around the World

With over two decades of experience, BeamMed is known for delivering diagnostic tools that combine clinical-grade accuracy with real-world practicality. The release of these two product offerings aligns with BeamMed’s vision of making advanced diagnostics accessible beyond large hospitals and into the hands of primary care providers, mobile health teams, and wellness advocates across the globe.

“Our goal has always been to create solutions that support preventive care, reduce long-term healthcare costs, and ultimately improve the quality of life for patients,” said Gilad Zamir, at BeamMed. “These devices allow providers to screen more patients, more often, and in more settings—without compromising on accuracy or usability.”

These devices are being adopted by healthcare providers across the United States, helping clinicians detect early signs of disease and make proactive care decisions. With the addition of the AI-Powered Fundus Camera and the continued success of the Mini Omni™, BeamMed is strengthening its role as a trusted leader in point-of-care diagnostics nationwide.

About BeamMed Inc.

BeamMed’s product line offers innovative, non-invasive diagnostic solutions focused on bone and ocular health. Widely used across clinics, hospitals, and mobile healthcare programs throughout the U.S., these tools are designed to make early detection more accessible, efficient, and accurate. With a strong emphasis on usability and clinical performance, BeamMed’s offerings continue to support the advancement of preventive care nationwide.

For more information about BeamMed and its full line of diagnostic solutions, visit https://www.beammed.com

Media Contact
Company Name: BeamMed Inc.
Contact Person: Gilad Zamir
Email: Send Email
Phone: 800-769-6808
Address:950 S. Pine Island Road
City: Plantation
State: Florida
Country: United States
Website: www.beammed.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: BeamMed Inc. Unveils Next-Generation Diagnostic Solutions: The Mini Omni™ Bone Density Scanner and AI-Powered Fundus Camera Lead the Way in Preventive Healthcare

eLearning Solutions Company Unveils Revamped Product Line Featuring Advanced AI-Based Training Solutions

New York, NY – July 14, 2025 – eLearning Company, Inc., doing business as eLearning Solutions Company, one of the top elearning companies and premier USA-based elearning development company, today announced a significant revamp of its product line. The company is now incorporating cutting-edge AI-based training solutions alongside its existing portfolio of traditional elearning offerings.

As a leading elearning vendor and one of the most respected elearning software companies, eLearning Solutions Company has earned a reputation for delivering fully customized, impactful courses tailored to diverse industries. Their products include engaging online courses, workplace training, interactive exercises, microlearning modules, and compliance programs, serving sectors such as government administration, healthcare, higher education, and human resources.

“Our revamped product line reflects our commitment to innovation and responsiveness to evolving client needs,” said a senior executive at eLearning Solutions Company. “The integration of advanced AI-based solutions allows us to provide more personalized, efficient, and immersive learning experiences, significantly enhancing learner engagement and training outcomes.”

Key innovations introduced with this revamp include:

  • Interactive Conversational Chatbots: Realistic dialogue simulations provide learners with immersive, interactive practice scenarios. These chatbots enable learners to engage in realistic conversations, enhancing their communication and problem-solving skills through dynamic, conversational interactions.
  • Automated Assignment and Scenario Creation: AI-generated assignments and scenarios significantly reduce content development time, enhancing instructional design processes. By automating these processes, organizations can rapidly produce tailored, realistic learning scenarios, freeing up instructional designers to focus on strategic content planning.
  • Intelligent Feedback for Assessments: Learners receive personalized, real-time feedback, promoting deeper understanding and skill mastery. This intelligent feedback adapts to individual performance, pinpointing strengths and identifying areas for improvement, resulting in a more efficient and targeted learning process.
  • Interactive Scenarios and Simulations: Real-world scenarios, powered by AI, enable practical, hands-on virtual training experiences. Learners can immerse themselves in simulations that mimic actual workplace challenges, fostering decision-making skills and critical thinking in a safe and controlled environment.
  • Personalization and Adaptive Learning Paths: AI-driven personalization ensures each learner’s experience is unique, relevant, and effective. Customized learning paths adjust dynamically to learner performance, interests, and preferences, increasing engagement and ensuring learning goals are effectively met.

“We are excited about the transformative potential of AI in learning,” continued the executive. “By leveraging AI’s power, we’re able to offer learning solutions that are not only advanced and effective but uniquely tailored to the specific needs of every client.”

The updated product line and AI-powered solutions are immediately available for client demonstrations and implementation.

About eLearning Solutions Company

eLearning Solutions Company, headquartered in New York, NY, is among the top elearning production companies, specializing in developing custom online learning solutions across multiple industries, including healthcare, finance, manufacturing, government, and education. The company’s current products include engaging online courses, workplace training, interactive exercises, hands-on learning activities, microlearning courses, custom learning courses, learning infographics, corporate training programs, professional learning courses, and compliance courses. Known for its creativity and deep industry expertise, eLearning Solutions Company delivers high-quality, tailored online learning experiences that are effective, engaging, and impactful.

For more information, or to request a product demonstration, please visit https://elearning.company/

Media Contact
Company Name: eLearning Company, Inc.
Contact Person: Jonas Axelsson
Email: Send Email
Country: United States
Website: https://elearning.company/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: eLearning Solutions Company Unveils Revamped Product Line Featuring Advanced AI-Based Training Solutions

Endometriosis Pain Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Endometriosis Pain pipeline constitutes 5+ key companies continuously working towards developing 5+ Endometriosis Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

 

Endometriosis Pain Pipeline Insight, 2025 report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Endometriosis Pain Market.

 

The Endometriosis Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

Some of the key takeaways from the Endometriosis Pain Pipeline Report:

  • Companies across the globe are diligently working toward developing novel Endometriosis Pain treatment therapies with a considerable amount of success over the years.

  • Endometriosis Pain companies working in the treatment market are Organon, Ironwood Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, AbbVie/Neurocrine Biosciences, ObsEva/Kissei Pharmaceuticals, SWK/Enteris BioPharma, Bayer/Hope Medicine, Tiumbio, and others, are developing therapies for the Endometriosis Pain treatment

  • Emerging Endometriosis Pain therapies in the different phases of clinical trials are- FOR 6219, IW-3300, MT-2990, ORIAHNN (elagolix/estradiol/norethindrone acetate), Linzagolix (OBE2109), OVAREST (leuprorelin oral), HMI-115, TU2670 (NCE-403), OG-6219, and others are expected to have a significant impact on the Endometriosis Pain market in the coming years.

  • In July 2025, A drug candidate once described by Organon as its “biggest potential opportunity” failed in a Phase 2 clinical trial, leading the company to discontinue its development for endometriosis. Organon, a women’s health-focused company, acquired the candidate OG-6219 through its $75 million acquisition of Forendo Pharma in 2021, shortly after spinning off from Merck & Co. The company launched a Phase 2 trial in 2022, enrolling 354 premenopausal women suffering from moderate to severe endometriosis-related pain. Participants were randomized to receive one of three doses of OG-6219 or a placebo. Organon had hoped the drug would alleviate pain by inhibiting a hormone involved in uterine tissue growth and inflammation, but the trial failed to meet expectations.

  • In March 2025, The first long-term daily oral treatment for endometriosis has been recommended for routine use on the NHS in England. In its final draft guidance, the National Institute for Health and Care Excellence (NICE) advised that relugolix-estradiol-norethisterone, also known as relugolix combination therapy (relugolix CT), should be offered to adults of reproductive age whose endometriosis symptoms persist despite previous medical or surgical treatments. This marks the first time a daily pill of this kind has been approved for long-term endometriosis management by the NHS, with around 1,000 women expected to benefit each year.

  • In October 2024, Lisata Therapeutics, Inc. entered into a sponsored research collaboration with the University of Cincinnati to explore its innovative cyclic peptide candidate, certepetide, in combination with bevacizumab (a VEGF inhibitor). The study will utilize a preclinical animal model to evaluate the potential of this combination therapy for treating endometriosis.

  • In October 2024, Hope Medicine Inc. reported positive findings from an interim analysis of its global Phase II trial, titled “A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of HMI-115 in Women with Moderate to Severe Endometriosis-Associated Pain Over a 12-Week Treatment Period.” HMI-115, a monoclonal antibody that inhibits the prolactin receptor, represents a first-in-class therapy for endometriosis. Notably, the National Medical Products Administration (NMPA) in China has granted HMI-115 Breakthrough Therapy Designation.

  • In May 2024, Neurocrine Biosciences, Inc. has commenced its Phase I first-in-human clinical trial to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the investigational drug NBI-1117567 in healthy adults. NBI-1117567 is an experimental oral selective muscarinic agonist, with a preference for M1 over M4 receptors, being developed as a potential treatment for neurological and neuropsychiatric disorders

  • In May 2024, TiumBio Co., Ltd., a company dedicated to developing innovative treatments for rare and incurable diseases, reported positive topline results from its Phase 2a clinical trial evaluating Merigolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, for the treatment of moderate to severe endometriosis-associated pain.

  • In April 2024, By the end of this year, Gynica, an Israeli company, plans to administer the first dose in a Phase I trial for its cannabinoid-based therapies, IntraVagS301 and IntraVagS302, designed for endometriosis. This trial aims to assess the safety, toxicity, and pharmacokinetics of these drugs, which utilize microencapsulation technology

 

Endometriosis Pain Overview

Endometriosis pain refers to the discomfort, cramping, and other symptoms experienced by individuals with endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus. The pain associated with endometriosis can vary widely in intensity and may occur before, during, or after menstruation. It can also manifest as chronic pelvic pain, lower back pain, and pain during bowel movements or urination.

 

Get a Free Sample PDF Report to know more about Endometriosis Pain Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/endometriosis-pain-pipeline-insight

 

Emerging Endometriosis Pain Drugs Under Different Phases of Clinical Development Include:

  • FOR 6219: Organon

  • IW-3300: Ironwood Pharmaceuticals

  • MT-2990: Mitsubishi Tanabe Pharma Corporation

  • ORIAHNN (elagolix/estradiol/norethindrone acetate): AbbVie/Neurocrine Biosciences

  • Linzagolix (OBE2109): ObsEva/Kissei Pharmaceuticals

  • OVAREST (leuprorelin oral): SWK/Enteris BioPharma

  • HMI-115: Bayer/Hope Medicine

  • TU2670 (NCE-403): Tiumbio

  • OG-6219: Organon

  • Quinagolide: Ferring Pharmaceuticals

  • Linzagolix: ObsEva

 

Endometriosis Pain Route of Administration

Endometriosis Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

  • Inhalation

  • Inhalation/Intravenous/Oral

  • Intranasal

  • Intravenous

  • Intravenous/ Subcutaneous

  • NA

  • Oral

  • Oral/intranasal/subcutaneous

  • Parenteral

  • Subcutaneous

 

Endometriosis Pain Molecule Type

Endometriosis Pain Products have been categorized under various Molecule types, such as

  • Antibody

  • Antisense oligonucleotides

  • Immunotherapy

  • Monoclonal antibody

  • Peptides

  • Protein

  • Recombinant protein

  • Small molecule

  • Stem Cell

  • Vaccine

 

Endometriosis Pain Pipeline Therapeutics Assessment

  • Endometriosis Pain Assessment by Product Type

  • Endometriosis Pain By Stage and Product Type

  • Endometriosis Pain Assessment by Route of Administration

  • Endometriosis Pain By Stage and Route of Administration

  • Endometriosis Pain Assessment by Molecule Type

  • Endometriosis Pain by Stage and Molecule Type

 

DelveInsight’s Endometriosis Pain Report covers around 5+ products under different phases of clinical development like

  • Late-stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I)

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

  • Route of Administration

 

Further Endometriosis Pain product details are provided in the report. Download the Endometriosis Pain pipeline report to learn more about the emerging Endometriosis Pain therapies

 

Some of the key companies in the Endometriosis Pain Therapeutics Market include:

Key companies developing therapies for Endometriosis Pain are – AbbVie, Neurocrine Biosciences, Kissei Pharmaceuticals, SWK, Enteris BioPharma, Bayer, Hope Medicine, Tiumbio, Organon, Ferring Pharmaceuticals, ObsEva SA, Myovant Sciences, Hope Medicine (Nanjing) Co., Ltd, TiumBio Co., Ltd., Mitsubishi Tanabe Pharma, and others.

 

Endometriosis Pain Pipeline Analysis:

The Endometriosis Pain pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Endometriosis Pain with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Endometriosis Pain Treatment.

  • Endometriosis Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Endometriosis Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Endometriosis Pain market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Endometriosis Pain drugs and therapies

 

Endometriosis Pain Pipeline Market Drivers

  • The development of drug delivery systems represents a new approach in pain treatment among endometriosis patients, extensive research on Non-steroidal anti-inflammatory drugs are some of the important factors that are fueling the Endometriosis Pain Market.

 

Endometriosis Pain Pipeline Market Barriers

  • However, less robust pipeline, high cost of treatment procedures and other factors are creating obstacles in the Endometriosis Pain Market growth.

 

Scope of Endometriosis Pain Pipeline Drug Insight

  • Coverage: Global

  • Key Spinal Cord Injury Companies: Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others

  • Key Endometriosis Pain Therapies: FOR 6219, IW-3300, MT-2990, ORIAHNN (elagolix/estradiol/norethindrone acetate), Linzagolix (OBE2109), OVAREST (leuprorelin oral), HMI-115, TU2670 (NCE-403), OG-6219, and others

  • Endometriosis Pain Therapeutic Assessment: Endometriosis Pain current marketed and Endometriosis Pain emerging therapies

  • Endometriosis Pain Market Dynamics: Endometriosis Pain market drivers and Endometriosis Pain market barriers

 

Request for Sample PDF Report for Endometriosis Pain Pipeline Assessment and clinical trials

 

Table of Contents

1. Endometriosis Pain Report Introduction

2. Endometriosis Pain Executive Summary

3. Endometriosis Pain Overview

4. Endometriosis Pain- Analytical Perspective In-depth Commercial Assessment

5. Endometriosis Pain Pipeline Therapeutics

6. Endometriosis Pain Late Stage Products (Phase II/III)

7. Endometriosis Pain Mid Stage Products (Phase II)

8. Endometriosis Pain Early Stage Products (Phase I)

9. Endometriosis Pain Preclinical Stage Products

10. Endometriosis Pain Therapeutics Assessment

11. Endometriosis Pain Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Endometriosis Pain Key Companies

14. Endometriosis Pain Key Products

15. Endometriosis Pain Unmet Needs

16 . Endometriosis Pain Market Drivers and Barriers

17. Endometriosis Pain Future Perspectives and Conclusion

18. Endometriosis Pain Analyst Views

19. Appendix

20. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Endometriosis Pain Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine